Legal Insights

< back to search results

FDA sets the stage for Cures Act breakthrough devices program in highly anticipated guidance document

Overview

On October 25, 2017, FDA released a critical draft guidance on the breakthrough medical device pathway established by the 21st Century Cures Act.


This briefing outlines the proposals.